Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Wahana Inti Makmur Tbk. (NASI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Wahana Inti Makmur Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Wahana Inti Makmur Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Wahana Inti Makmur Tbk. trades at Rp130 (market cap 106.58B, 400.5K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Wahana Inti Makmur Tbk. is more actively traded (400.5K versus 62.5K). Which is the better fit depends on your goals.

NASIOBAT
Market Cap
106.58B164.65B
Volume
400.5K62.5K
Lot
4.01K625
Turnover
52.47M15.03M
Average Price
131240.55
Value
52.47M15.03M
Indicative Equilibrium Price
130238
Indicative Equilibrium Volume
293100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NASI
View details
OBAT
View details

About Wahana Inti Makmur Tbk.

PT Wahana Inti Makmur Tbk (the Company) is established based on Deed of Establishment No. 02 dated February 14, 2015 made by Dr. Tio Jeffrens Maranella, S.H., Notary in Jakarta. The Company started its commercial operations in February 2015.

Read more on NASI

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT